Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity

被引:10
作者
Brophy, Susan E. [1 ]
Jones, Lindsay L. [1 ]
Holler, Phillip D. [1 ]
Kranz, David M. [1 ]
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
关键词
MHC; antigen presentation/processing; T cells;
D O I
10.1016/j.molimm.2006.11.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The T cell stimulatory activity of peptides is known to be associated with the cell surface stability and lifetime of the peptide-MHC (pepMHC) complex. In this report, soluble high-affinity T cell receptors (TCRs) that are specific for pepMHC complexes recognized by the mouse CD8(+) clone 2C were used to monitor the cell surface lifetimes of synthetic agonist peptides. In the 2C system, L-d-binding peptide p2Ca (LSPFPFDL) has up to 10,000-fold lower activity than peptide QL9 (QLSPFPFDL) even though the 2C TCR binds to p2Ca-L-d and QL9-L-d complexes with similar affinities. Unexpectedly, p2Ca-L-d complexes were found to have a longer cell surface lifetime than QL9-Ld complexes. However, the strong agonist activity of QL9 correlated with its ability to participate in efficient intracellular delivery followed by cell surface expression of the peptide, resulting in high and persistent surface levels of QL9-L-d. The ability of target cells to take up and present QL9 was observed with TAP-deficient cells and TAP-positive cells, including dendritic cells. The process was brefeldin A-sensitive, indicating a requirement for transport of the pepMHC through the ER and/or golgi. Thus, strong T cell stimulatory activity of some pepMHC complexes can be accomplished not only through long cell surface lifetimes of the ligand, but through a mechanism that leads to delayed presentation of the exogenous antigen after intracellular uptake. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2184 / 2194
页数:11
相关论文
共 56 条
[1]   Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells [J].
Ackerman, AL ;
Kyritsis, C ;
Tampé, R ;
Cresswell, P .
NATURE IMMUNOLOGY, 2005, 6 (01) :107-113
[2]   Cellular mechanisms governing cross-presentation of exogenous antigens [J].
Ackerman, AL ;
Cresswell, P .
NATURE IMMUNOLOGY, 2004, 5 (07) :678-684
[3]   DIFFERENTIAL TRANSPORT REQUIREMENTS OF HLA AND H-2 CLASS-I GLYCOPROTEINS [J].
ALEXANDER, J ;
PAYNE, JA ;
MURRAY, R ;
FRELINGER, JA ;
CRESSWELL, P .
IMMUNOGENETICS, 1989, 29 (06) :380-388
[4]   A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells [J].
Andersen, PS ;
Stryhn, A ;
Hansen, BE ;
Fugger, L ;
Engberg, J ;
Buus, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1820-1824
[5]   Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling [J].
Baker, BM ;
Gagnon, SJ ;
Biddison, WE ;
Wiley, DC .
IMMUNITY, 2000, 13 (04) :475-484
[6]   CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1283-1288
[7]   Requirements for peptide-induced T cell receptor downregulation on naive CD8(+) T cells [J].
Cai, ZL ;
Kishimoto, H ;
Brunmark, A ;
Jackson, MR ;
Peterson, PA ;
Sprent, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :641-651
[8]  
Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.3.CO
[9]  
2-O
[10]   Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH [J].
Chefalo, PJ ;
Grandea, AG ;
Van Kaer, L ;
Harding, CV .
JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :5825-5833